Mostrar registro simples

dc.rights.licensehttp://creativecommons.org/licenses/by-nc-sa/3.0/ve/es_VE
dc.contributor.authorHamdan-Sánchez, Mager
dc.contributor.authorRojas, Luis B.
dc.contributor.authorObregón Díaz, Ysbelia
dc.contributor.authorAparicio Z., Rosa L.
dc.contributor.authorPérez Colmenares, Alida
dc.contributor.authorCordero de Rojas, Yndra
dc.contributor.authorDíaz, Clara
dc.contributor.authorDa Silva-Rojas, Jossblerys
dc.contributor.authorUsubillaga, Alfredo
dc.date.accessioned2022-07-20T15:53:15Z
dc.date.available2022-07-20T15:53:15Z
dc.date.issued2022-07-20
dc.identifier.issn0543- 517-X
dc.identifier.urihttp://www.saber.ula.ve/handle/123456789/48327
dc.description.abstractLa obtención de seis nuevos derivados hemisintéticos a partir de ent-kaurenol (I), se realizó mediante la reacción de esterificación de Steglich empleando los ácidos p-cloro-fenil-acético, o-cloro-fenil-acético, m-cloro-fenil-acético, p-bromo-fenil-acético, nicotínico y salicílico; utilizando la combinación de diciclohexilcarbodiimida (DCC, agente de acoplamiento), 4-dimetilaminopiridina (DMAP, catalizador nucleofílico) y como solvente el diclorometano. Todos los compuestos fueron caracterizados mediante técnicas espectroscópicas de IR y RMN uni y bidimensionales, lográndose identificar como ent-kaur-19-O-[2’-(p-cloro-fenil)-carboximetil]-16-eno (II), ent-kaur-19-O-[2´-(o-cloro-fenil)- carboximetil]-16-eno (III), ent-kaur-19-O-[2’-(m-cloro-fenil)-carboximetil]-16-eno (IV), ent-kaur-19-O-[2’-(p-bromo- fenil)-carboximetil]-16-eno (V), ent-kaur-19-O-(m-piridil-carboxil)-16-eno (VI) y ent-kaur-19-O-(o-hidroxi-fenil- carboxil)-16-eno (VII). Estos compuestos no presentaron actividad antimicrobiana mediante el método de difusión en agar en pozo frente a cepas ATCC de Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa y Candida albicans a una concentración de 2 mg/mL.es_VE
dc.language.isoeses_VE
dc.publisherSaberULAes_VE
dc.rightsinfo:eu-repo/semantics/openAccesses_VE
dc.subjectDiterpenoses_VE
dc.subjectEnt-kaurenoes_VE
dc.subjectEnt-kaurenoles_VE
dc.subjectEsterificación de Stegliches_VE
dc.subjectActividad antimicrobianaes_VE
dc.titleDerivados hemisintéticos del ent-kaurenol y evaluación de su actividad antimicrobianaes_VE
dc.title.alternativeHemisynthetic derivatives of ent-kaurenol and evaluation of their antimicrobial activityes_VE
dc.typeinfo:eu-repo/semantics/articlees_VE
dcterms.dateAcceptedjunio de 2022
dcterms.dateSubmittedmarzo de 2022
dc.description.abstract1Hemisynthetic derivatives of ent-kaurenol and evaluation of their antimicrobial activity. Six new hemisynthetic derivatives were obtained from ent-kaurenol (I), this was performed by the Steglich esterification reaction using p-chloro-phenyl-acetic acid, o-chloro-phenyl-acetic acid, m-chloro-phenyl-acetic, p- bromo-phenyl-acetic, nicotinic and salicylic; using the combination of dicyclohexylcarbodiimide (DCC, coupling agent), 4-dimethylaminopyridine (DMAP, nucleophilic catalyst) and dichloromethane as solvent. All compounds were characterized by one- and two-dimensional NMR,IR spectroscopic techniques and were identified as ent-kaur-19-O-[2'- (p-chloro-phenyl)-carboxymethyl]-16-ene (II), ent-kaur-19-O-[2’-(o-chloro-phenyl)-carboxymethyl]-16-ene (III), ent- kaur-19-O-[2’-(m-chloro-phenyl)-carboxymethyl]-16-ene (IV), ent-kaur-19-O-[2´-(p-bromo-phenyl)-carboxymethyl]-16-ene (V), ent-kaur-19-O-(m-pyridyl-carboxyl)-16-ene (VI) and ent-kaur-19-O-(o-hydroxy-phenyl-carboxyl-16-ene (VII). These compounds did not exhibit antimicrobial activity by the well agar diffusion method against ATCC strains of Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa and Candida albicans at the concentration of 2 mg/mL.es_VE
dc.description.colacion20-28es_VE
dc.description.emailysbeliaobregon@gmail.comes_VE
dc.description.frecuenciaSemestral
dc.description.paginawebhttp://www.saber.ula.ve/farmacia/
dc.identifier.depositolegalpp195802ME1003
dc.identifier.edepositolegalppi201202ME4102
dc.identifier.eissn2244-8845
dc.publisher.paisVenezuelaes_VE
dc.subject.institucionUniversidad de Los Andeses_VE
dc.subject.keywordsDiterpeneses_VE
dc.subject.keywordsEnt-kaurenees_VE
dc.subject.keywordsEnt-kaurenoles_VE
dc.subject.keywordsSteglich esterificationes_VE
dc.subject.keywordsHemisynthetic derivativeses_VE
dc.subject.seccionRevista de la Facultad de Farmacia: Artículoses_VE
dc.subject.tipoArtículoses_VE
dc.type.mediaTextoes_VE
dc.identifier.doihttps://doi.org/10.53766/REFA/2022.64.01.03es


Arquivos deste item

Thumbnail

Este item aparece na(s) seguinte(s) coleção(s)

Mostrar registro simples